Skip to main content Skip to main navigation menu Skip to site footer
Articles
Published: 2023-08-24

Intersecting paths: A rare case report of malignant melanoma in a patient with body dysmorphic disorder

Jorhat medical college and hospital, Assam, India
Department of Psychiatry, Lakhimpur Medical College and Hospital, India.

Abstract

Background: Body dysmorphic disorder (BDD) characterized by excessive and persistent preoccupation with perceived defects or flaws in appearance and has a prevalence of 1.7-2.9%. It is a disorder with a relatively unclear etiology.

Case presentation: A 36-year-old unmarried female presented to the surgery department with a self-inflicted lesion on her right ankle. The patient underwent fine needle aspiration cytology, and later, a wide local excision of the lesion was done. The final histological diagnosis of malignant melanoma was established. On careful psychiatric evaluation, the patient had an excessive and persistent preoccupation with her appearance, which caused severe psychological and social morbidity and drove her to her actions. Thus, the final diagnosis of body dysmorphic disorder (DSM V) was established. The patient was put on Fluoxetine and cognitive behavioral therapy.

Conclusion: Given the significantly reduced functionality and quality of life, BDD should be recognized and accurately diagnosed.



Downloads

Download data is not yet available.

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed VA: Arlington American Psychiatric Publishing 2013.
  2. Prevalence of BDD. Available at: https://bdd.iocdf.org/professionals/prevalence/ (Accessed: February 22, 2023).
  3. Morselli E. Sulla dismorfofobia e sulla tafefobia. Bolletinno della R Accademia di Genova. 1891; 6: 110–119.
  4. First MB, Gaebel W, Maj M, Stein DJ, Kogan CS, Saunders JB, Poznyak VB, Gureje O, Lewis-Fernández R, Maercker A, Brewin CR, Cloitre M, Claudino A, Pike KM, Baird G, Skuse D, Krueger RB, Briken P, Burke JD, Lochman JE, Reed GM. An organization- and category-level comparison of diagnostic requirements for mental disorders in ICD-11 and DSM-5. World psychiatry: official journal of the World Psychiatric Associatio. 2021; 20(1): 34–51. https://doi.org/10.1002/wps.20825.
  5. Hakim RF, Alrahmani DA, Ahmed DM, Alharthi NA, Fida AR, Al-Raddadi RM. Association of body dysmorphic disorder with anxiety, depression, and stress among university students. J Taibah Univ Med Sci. 2021;16(5):689-694. Published 2021 Jun 12. doi: 10.1016/j.jtumed.2021.05.008.
  6. Schut C, Dalgard FJ, Bewley A, Evers AWM, Gieler U, Lien L, et al. Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries. Br J Dermatol. 2022;187(1):115-125. doi:10.1111/bjd.21021.
  7. Bahrami M, Mohamadirizi M, Mohamadirizi S, Hosseini SA. Evaluation of body image in cancer patients and its association with clinical variables. J Educ Health Promot. 2017 Oct 4; 6:81. doi: 10.4103/jehp.jehp_4_15.
  8. Michielin O, van Akkooi ACJ, Ascierto PA, Dummer R, Keilholz U; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019;30(12):1884-1901. doi:10.1093/annonc/mdz41.
  9. Buhlmann U, Glaesmer H, Mewes R, et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res. 2010;178(1):171-175. doi: 10.1016/j.psychres.2009.05.002.
  10. Phillips KA. Body dysmorphic disorder: recognizing and treating imagined ugliness. World Psychiatry. 2004 Feb;3(1):12-7.
  11. Boquiren VM, Esplen MJ, Wong J, Toner B, Warner E, Malik N. Sexual functioning in breast cancer survivors experiencing body image disturbance. Psychooncology. 2016;25(1):66-76. https://doi.org/10.1002/pon.3819.
  12. Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology.2008;17(4):317-328. doi:10.1002/pon.1245.
  13. Shellenberger R, Nabhan M, Kakaraparthi S. Melanoma screening: A plan for improving early detection. Ann Med. 2016;48(3):142-148. doi:10.3109/07853890.2016.1145795.
  14. Keung EZ, Gershenwald JE. Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma. J Natl Cancer Inst. 2020;112(9):875-885. doi:10.1093/jnci/djaa012.
  15. Castle DJ, Phillips KA, Dufresne RG Jr. Body dysmorphic disorder and cosmetic dermatology: more than skin deep. J Cosmet Dermatol. 2004;3(2):99-103. doi:10.1111/j.1473-2130.2004. 00105.x


How to Cite

1.
Bhuyan G, Rabha A. Intersecting paths: A rare case report of malignant melanoma in a patient with body dysmorphic disorder. jidhealth [Internet]. 2023 Aug. 24 [cited 2024 May 18];6(3):895-8. Available from: https://www.jidhealth.com/index.php/jidhealth/article/view/292